Iberdomide increases innate and adaptive immune cell subsets in the bone marrow of patients with relapsed/refractory multiple myeloma.
Van Oekelen O. et al, (2024), Cell rep med, 5
Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination.
Twumasi C. et al, (2024), Eur j haematol, 112, 547 - 553
KMT2A associates with PHF5A-PHF14-HMG20A-RAI1 subcomplex in pancreatic cancer stem cells and epigenetically regulates their characteristics.
Mouti MA. et al, (2023), Nat commun, 14
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.
Kurata K. et al, (2023), Blood cancer j, 13
Long-Read Single-Cell Sequencing Using scCOLOR-seq.
Philpott M. et al, (2023), Methods mol biol, 2632, 259 - 267
Recognition of Dimethylarginine Analogues by Tandem Tudor Domain Protein Spindlin1
Porzberg MRB. et al, (2022), Molecules, 27, 983 - 983
Nanopore sequencing of single-cell transcriptomes with scCOLOR-seq.
Philpott M. et al, (2021), Nat biotechnol, 39, 1517 - 1520
Neuropeptide S receptor 1 is a nonhormonal treatment target in endometriosis.
Tapmeier TT. et al, (2021), Sci transl med, 13
Neuropeptide S receptor 1 is a nonhormonal treatment target in endometriosis.
Tapmeier TT. et al, (2021), Sci transl med, 13
AF10 (MLLT10) prevents somatic cell reprogramming through regulation of DOT1L-mediated H3K79 methylation.
Uğurlu-Çimen D. et al, (2021), Epigenetics chromatin, 14
Lysine Demethylase 5A is Required for MYC Driven Transcription in Multiple Myeloma.
Ohguchi H. et al, (2021), Cancer discov, 2, 370 - 387
KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas.
Heward JA. et al, (2021), Blood
The Prolyl-tRNA Synthetase Inhibitor Halofuginone Inhibits SARS-CoV-2 Infection.
Sandoval DR. et al, (2021), Biorxiv
Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy
NIBHANI R., (2021), Nature communications
Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy
OPPERMANN UDO., (2021), Nature communications
A Chemo-Genomic Approach Identifies Diverse Epigenetic Therapeutic Vulnerabilities in MYCN-Amplified Neuroblastoma.
Krstic A. et al, (2021), Front cell dev biol, 9